BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11173689)

  • 1. [Treatment of keratoacanthoma with intralesional methotrexate injections].
    Richard MA; Gachon J; Choux R; Laurans R; Folchetti G; Grob JJ
    Ann Dermatol Venereol; 2000 Dec; 127(12):1097. PubMed ID: 11173689
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple keratoacanthomas occurring in surgical margins and de novo treated with intralesional methotrexate.
    Veerula VL; Ezra N; Aouthmany M; Graham TA; Wolverton SE; Somani AK
    Cutis; 2016 Dec; 98(6):E12-E15. PubMed ID: 28099546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intralesional methotrexate injection: an effective time and cost saving therapy alternative in keratoacanthomas that are difficult to treat surgically].
    Remling R; Mempel M; Schnopp N; Abeck D; Ring J
    Hautarzt; 2000 Aug; 51(8):612-4. PubMed ID: 10997318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of keratoacanthomas with intralesional methotrexate.
    Melton JL; Nelson BR; Stough DB; Brown MD; Swanson NA; Johnson TM
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 1):1017-23. PubMed ID: 1810980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the first-line treatment of keratoacanthomas surgical excision or injection of intralesional chemotherapy?
    Hoegler KM; Schleichert RA
    J Am Acad Dermatol; 2020 Nov; 83(5):1542-1543. PubMed ID: 32622139
    [No Abstract]   [Full Text] [Related]  

  • 6. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature.
    Annest NM; VanBeek MJ; Arpey CJ; Whitaker DC
    J Am Acad Dermatol; 2007 Jun; 56(6):989-93. PubMed ID: 17504715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressive giant keratoacanthoma of the face treated with intramuscular methotrexate and triamcinolone acetonide.
    Santoso-Pham JC; Shelley ED; Shelley WB
    Cutis; 1997 Jun; 59(6):329-32. PubMed ID: 9218892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralesional methotrexate in solitary keratoacanthoma.
    Cuesta-Romero C; de Grado-Peña J
    Arch Dermatol; 1998 Apr; 134(4):513-4. PubMed ID: 9580539
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intralesional infusion of methotrexate as neoadjuvant therapy improves the cosmetic and functional results of surgery to treat keratoacanthoma: results of a randomized trial].
    Martorell-Calatayud A; Requena C; Nagore E; Sanmartín O; Serra-Guillén C; Botella-Estrada R; Sanz-Motilva V; Llombart B; Alcañiz-Moscardo A; Guillén-Barona C
    Actas Dermosifiliogr; 2011 Oct; 102(8):605-15. PubMed ID: 21742301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralesional therapy for the treatment of keratoacanthoma.
    Kiss N; Avci P; Bánvölgyi A; Lőrincz K; Szakonyi J; Gyöngyösi N; Fésűs L; Lee G; Wikonkál N
    Dermatol Ther; 2019 May; 32(3):e12872. PubMed ID: 30866135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Keratoacanthoma: 157 Tumors Treated With Surgery or Intralesional Methotrexate.
    Moss M; Weber E; Hoverson K; Montemarano AD
    Dermatol Surg; 2019 Jul; 45(7):877-883. PubMed ID: 30608293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriasis of the lips: an unusual localization.
    Gül U; Kiliç A; Gönül M; Soylu S; Bilgili S; Han O
    Int J Dermatol; 2006 Nov; 45(11):1381-2. PubMed ID: 17076738
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of giant keratoacanthoma of the skin of the lower lip with intralesional methotrexate: a case report.
    de Visscher JG; van der Wal KG; Blanken R; Willemse F
    J Oral Maxillofac Surg; 2002 Jan; 60(1):93-5. PubMed ID: 11757016
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of keratoacanthoma with trichloroacetic acid].
    Lańcucki J; Samochocki Z
    Przegl Dermatol; 1982; 69(5-6):465-8. PubMed ID: 6764681
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of Ufudix ointment for the treatment of keratoacanthoma. I. Clinical evaluation of the results].
    Starzycki Z
    Przegl Dermatol; 1980; 67(4):469-74. PubMed ID: 7001547
    [No Abstract]   [Full Text] [Related]  

  • 16. Cutaneous Rosai-Dorfman disease successfully treated with low-dose methotrexate.
    Sun NZ; Galvin J; Cooper KD
    JAMA Dermatol; 2014 Jul; 150(7):787-8. PubMed ID: 24789266
    [No Abstract]   [Full Text] [Related]  

  • 17. [Facial angioedema following hyaluronic acid injection].
    Stephan F; Maatouk I; Moutran R; Obeid G
    Ann Dermatol Venereol; 2012 Jan; 139(1):63-4. PubMed ID: 22225746
    [No Abstract]   [Full Text] [Related]  

  • 18. Intralesional methotrexate in keratoacanthoma of the nose.
    Hurst LN; Gan BS
    Br J Plast Surg; 1995 Jun; 48(4):243-6. PubMed ID: 7640859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intralesional interferon alfa-2b treatment of keratoacanthomas.
    Oh CK; Son HS; Lee JB; Jang HS; Kwon KS
    J Am Acad Dermatol; 2004 Nov; 51(5 Suppl):S177-80. PubMed ID: 15577764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of interferon-alpha (IFN-alpha) in the treatment of keratoacanthoma].
    Somlai B; Holló P
    Hautarzt; 2000 Mar; 51(3):173-5. PubMed ID: 10789078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.